These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15220690)

  • 1. Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C.
    Rowan PJ; Tabasi S; Abdul-Latif M; Kunik ME; El-Serag HB
    J Clin Gastroenterol; 2004 Jul; 38(6):530-4. PubMed ID: 15220690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy.
    Rowan PJ; Al-Jurdi R; Tavakoli-Tabasi S; Kunik ME; Satrom SL; El-Serag HB
    J Clin Gastroenterol; 2005 Sep; 39(8):731-6. PubMed ID: 16082286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.
    Bini EJ; Bräu N; Currie S; Shen H; Anand BS; Hu KQ; Jeffers L; Ho SB; Johnson D; Schmidt WN; King P; Cheung R; Morgan TR; Awad J; Pedrosa M; Chang KM; Aytaman A; Simon F; Hagedorn C; Moseley R; Ahmad J; Mendenhall C; Waters B; Strader D; Sasaki AW; Rossi S; Wright TL
    Am J Gastroenterol; 2005 Aug; 100(8):1772-9. PubMed ID: 16086714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recreational Drug and Psychosocial Profile in Chronic Hepatitis C Patients Seeking Antiviral Therapy.
    George N; Harrell SM; Rhodes KD; Duarte-Rojo A
    Ann Hepatol; 2018; 17(1):76-84. PubMed ID: 29311404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial.
    Groessl EJ; Sklar M; Cheung RC; Bräu N; Ho SB
    Contemp Clin Trials; 2013 Jul; 35(2):97-107. PubMed ID: 23669414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection.
    Muir AJ; Provenzale D
    J Clin Gastroenterol; 2002 Mar; 34(3):268-71. PubMed ID: 11873110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression, anxiety, post-traumatic stress, and alcohol-related problems among veterans with chronic hepatitis C.
    Lehman CL; Cheung RC
    Am J Gastroenterol; 2002 Oct; 97(10):2640-6. PubMed ID: 12385453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating Hepatitis C in Homeless Veterans at the Greater Los Angeles Veterans' Affairs Medical Center.
    Bakr O; Gelberg L; Seragaki S; Youn S; Kawamoto J; Hoppe M; Altman L; Kopelson K; May FP; Cowan B; Bhattacharya D
    Hepatology; 2019 Sep; 70(3):1071-1073. PubMed ID: 30945758
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders.
    Chainuvati S; Khalid SK; Kancir S; Shea M; Edwards J; Sernyak M; Wongcharatrawee S; Garcia-Tsao G
    J Viral Hepat; 2006 Apr; 13(4):235-41. PubMed ID: 16611189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of disease in U.S. veteran patients with hepatitis C.
    Nguyen HA; Miller AI; Dieperink E; Willenbring ML; Tetrick LL; Durfee JM; Ewing SL; Ho SB
    Am J Gastroenterol; 2002 Jul; 97(7):1813-20. PubMed ID: 12135041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse.
    Ho SB; Bräu N; Cheung R; Liu L; Sanchez C; Sklar M; Phelps TE; Marcus SG; Wasil MM; Tisi A; Huynh L; Robinson SK; Gifford AL; Asch SM; Groessl EJ
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):2005-14.e1-3. PubMed ID: 25724704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of a Hepatitis C screening program at a large urban VA medical center.
    Groom H; Dieperink E; Nelson DB; Garrard J; Johnson JR; Ewing SL; Stockley H; Durfee J; Jonk Y; Willenbring ML; Ho SB
    J Clin Gastroenterol; 2008 Jan; 42(1):97-106. PubMed ID: 18097298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
    Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
    Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project.
    Lindenburg CE; Lambers FA; Urbanus AT; Schinkel J; Jansen PL; Krol A; Casteelen G; van Santen G; van den Berg CH; Coutinho RA; Prins M; Weegink CJ
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):23-31. PubMed ID: 21042221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression comorbidity and antidepressant use in veterans with chronic hepatitis C: results from a retrospective chart review.
    Nelligan JA; Loftis JM; Matthews AM; Zucker BL; Linke AM; Hauser P
    J Clin Psychiatry; 2008 May; 69(5):810-6. PubMed ID: 18426262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
    Fireman M; Indest DW; Blackwell A; Whitehead AJ; Hauser P
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S286-91. PubMed ID: 15768336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office.
    Yee HS; Chang MF; Pocha C; Lim J; Ross D; Morgan TR; Monto A; ;
    Am J Gastroenterol; 2012 May; 107(5):669-89; quiz 690. PubMed ID: 22525303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: results from a US database of over 45 000 HCV-infected, evaluated patients.
    Talal AH; LaFleur J; Hoop R; Pandya P; Martin P; Jacobson I; Han J; Korner EJ
    Aliment Pharmacol Ther; 2013 Feb; 37(4):473-81. PubMed ID: 23289640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.